International Congress on Oncology Research and Development (iCORD), October 05-06, 2019, Taj Palace, New Delhi

The International Congress on Oncology Research and Development (iCORD), will be held at Taj Palace, New Delhi, from October 05-06, 2019.

iCORD is an initiative to bring all stakeholders involved in cancer research and patient care to a common platform discuss and advocate the latest developments in oncology research, drugs/diagnostics, technology, therapies, and patient care programs. It’s an international annual event with aims to promote best in the class, high standard of care in line with global healthcare standards to cancer patients in India.

There are 30+ invited speakers in congress from India and abroad. The congress speakers include research experts from Industry, Patient Advocacy Groups and Practicing Oncologist across specialties from India and abroad. The conference agenda can be downloaded from  https://goicord.com/agenda/.

Conference registrations are open and delegates can enjoy early birds rates until  July 15 2019.

The congress will be attended by KOLs across oncology specialties (medical, radiation, surgical, pediatric), Hospitals, Academia, Industry professionals (pharmaceutical, medical biotechnology , medical device, medical imaging solution providers, CROs, SMOs, KPOs, clinical trial supplies storage and logistics providers, market research companies, molecular and central labs, diagnostic and radiological service providers, translation service providers, clinical trials and oncology research software/services providers), medical graduates, and patient advocacy and support groups. Its an excellent platform for clinical research companies to meet the KOLs involved in global oncology clinical trials and to discuss the feasibility of upcoming clinical trials.

The congress also feature an exhibition showcasing thenew biotech companies with clinical trials pipelines, clinical research centers/CROs/SMOs/central labs/image reading centers, electronic/software solutions providers engaged in oncology clinical trials, pharma/medical device companies, medical technology service providers, diagnostic imaging agents and radiopharmaceuticals companies with oncology portfolios and wellness solutions/products providers among other exhibitors.

iCORD vision is to translate all oncology research towards cancer patient care. The involvement and support of all stakeholders engaged in cancer patients treatment, support, product/services, research, and advocacy are welcome to support this initiative.

For more details on the iCORD, please visit www.goicord.com.

The Pharma Times News Bureau

Share
Published by
The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago